Nestle SA, 10% Owner at Aimmune Therapeutics, Inc. (AIMT), bought 13,727,113 shares at $31.97 ($237.0M) on 2020-02-07, disclosed to the SEC on 2020-04-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.97 | 1,000,000 | $32.0M | 13.5% |
| 2 | $16.11 | 12,727,113 | $205.0M | 86.5% |
| Total | $17.27 avg | 13,727,113 | $237.0M | 100% |